The Study Group was requested to undertake a preliminary evaluation of the Agency's existing research and risk assessment capabilities organisms. The Group concluded that although the Agency has increased its research staff and initiated a research program in biotechnology, a larger and broader program than that envisioned is needed by EPA decision makers. Evaluation of environmental effects, in particular, is an issue which should receive high priority by EPA. The Study Group endorsed EPA's current regulatory approach toward this developing industry.